The Board of Consun Pharmaceutical Group Limited announced that as a result of his resignation as an executive Director, Mr. AN Yubao has ceased to act as an authorised representative of the company under Rule 3.05 of the Rules Governing the Listing of Securities on the Stock Exchange of Hong Kong Limited ("Authorised Representative") with effect from 9 July 2021. Mr. AN Meng, an executive Director and the chairman of the Board, has been appointed as an Authorised Representative in place of Mr. An with effect from 9 July 2021.